Correlation Between Tarsus Pharmaceuticals and Sangamo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Sangamo Therapeutics, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Sangamo Therapeutics.
Diversification Opportunities for Tarsus Pharmaceuticals and Sangamo Therapeutics
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Tarsus and Sangamo is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Sangamo Therapeutics go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Sangamo Therapeutics
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.38 times more return on investment than Sangamo Therapeutics. However, Tarsus Pharmaceuticals is 2.63 times less risky than Sangamo Therapeutics. It trades about 0.28 of its potential returns per unit of risk. Sangamo Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 3,967 in Tarsus Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 857.00 from holding Tarsus Pharmaceuticals or generate 21.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Sangamo Therapeutics
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Sangamo Therapeutics |
Tarsus Pharmaceuticals and Sangamo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Sangamo Therapeutics
The main advantage of trading using opposite Tarsus Pharmaceuticals and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.| Tarsus Pharmaceuticals vs. Capricor Therapeutics | Tarsus Pharmaceuticals vs. Soleno Therapeutics | Tarsus Pharmaceuticals vs. Bio Path Holdings | Tarsus Pharmaceuticals vs. Moleculin Biotech |
| Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |